Why do we sneeze? Why do your eyes close? A pediatric nurse explains the science of sneezing
Why do we sneeze? – Naomi, 9, San Francisco, California
Why do people sneeze with their eyes closed? Is there a way for people to sneeze with their eyes open? – Carlos, 11, Riverview, Florida
Why do adults make a loud noise when they sneeze? – Artie, 8, Brooklyn, New York
Aaaaa-choo! While your first thought may be to say 'Gesundheit!' your second might be to ask: 'Where did that sneeze come from?'
Sneezing is a phenomenon that occurs in both people and animals. It happens when your body forcibly expels air from your lungs through your nose and mouth.
Most of the time, sneezing happens when something infectious, like a virus or bacteria, or irritating, like an allergen or chemical, enters your nostrils. Your body uses sneezing as a defense mechanism to clear your nose of mucus – also known as snot – and prevent foreign objects and particles from entering your airway.
But sneezing can also occur as a reaction to more unusual stimuli.
Chemicals like piperine or capsaicin found in foods like black pepper and chili peppers can irritate the nerve endings inside your nose's mucous membranes and lead to a sneeze.
Another type of sneeze is psychogenic, meaning it's caused by something more mental than physical. Though not fully understood, researchers believe it occurs when a strong emotion triggers your brain to send a chemical signal to your nose that makes you sneeze.
And finally, about one in four people experience something called photosneezia, or a photic sneeze reflex, where light, particularly sunlight, can trigger a sneeze.
Is it possible to sneeze without closing your eyes?
Despite a popular myth that sneezing with your eyes open will make them pop out, it's actually possible to keep your eyes open when you sneeze.
Closing your eyes during a sneeze is an autonomic reflex. This means that your body does it without you needing to consciously think about it. Scientists believe that your body makes your eyes close when you sneeze to decrease the likelihood of germs getting into them.
It's possible to fight that reflex and intentionally keep your eyes open. But it might be better to keep them closed to avoid getting the germs you expelled into your eyes.
Why do you make noises when you sneeze?
Some people have very loud sneezes, while others have more delicate sneezes.
The noise you make when you sneeze is a result of air escaping your mouth or nose. Generally, the more air you breathe in, the louder your sneeze will be. Like closing your eyes, inhaling prior to a sneeze is largely a reflex but could be consciously controlled as well.
Some people even hold in or 'swallow' their sneezes, though health experts don't recommend this due to potential risk for injury. Some sneezes can be so powerful they expel mucous droplets as forcefully as 100 miles per hour!
What is proper sneezing etiquette?
Although sneezing is sometimes just a reflex, or the result of an allergy or chemical irritation, sneezing can also be a symptom of a contagious illness or upper respiratory infection.
When you feel the urge to sneeze, best practice is to sneeze into a tissue or your sleeve to catch the germs that may come out with the air you expelled. If you caught your sneeze with a tissue or touched your nose and mouth, good hand hygiene, like washing with soap and water or using hand sanitizer, is especially important to help prevent spreading germs.
Whether you sneeze with your eyes open or closed, loudly or quietly, covering your mouth and nose when you sneeze and washing your hands for 20 seconds after can help protect others from getting sick.
Hello, curious kids! Do you have a question you'd like an expert to answer? Ask an adult to send your question to CuriousKidsUS@theconversation.com. Please tell us your name, age and the city where you live.
And since curiosity has no age limit – adults, let us know what you're wondering, too. We won't be able to answer every question, but we will do our best.
This article is republished from The Conversation, a nonprofit, independent news organization bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: Meg Sorg, Purdue University
Read more:
Why hand-washing really is as important as doctors say
Why do people faint?
Pollen is getting worse, but you can make things better with these tips from an allergist
Meg Sorg does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
Solve the daily Crossword
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic
-- GSK (NYSE:GSK) (LON:GSK) said on Monday that the U.S. Food and Drug Administration has accepted its priority review application for gepotidacin, an oral antibiotic aimed at treating sexually transmitted uncomplicated gonorrhoea. The drugmaker's shares climbed 1% in London on the news. The company is looking to new infectious disease products, including its recently launched respiratory syncytial virus vaccine, to offset expected revenue declines from top-selling medicines and looming patent expirations in its HIV portfolio. Gepotidacin is already approved in the U.S. under the brand name Blujepa for treating a common urinary tract infection in women and adolescent girls. The FDA is expected to decide in December on its use for uncomplicated urogenital gonorrhoea, which could offer patients an oral alternative to existing injectable treatments. Separately, GSK and Germany's CureVac last week resolved a long-running patent dispute with Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) over mRNA vaccine technology used during the COVID-19 pandemic. The settlement follows BioNTech's June agreement to acquire CureVac in an all-stock deal worth $1.25 billion to advance work on mRNA-based cancer therapies. Under the settlement, CureVac and GSK will receive $740 million and single-digit percentage royalties on future U.S. sales of COVID-19 vaccines, CureVac said. GSK's share amounts to $370 million, including $50 million to adjust terms from a 2024 licence agreement that expanded their pandemic-era partnership. If BioNTech's takeover of CureVac is completed, related mRNA litigation outside the U.S. will also be resolved, with GSK receiving an additional $130 million and royalties extended to non-U.S. sales. CureVac said the acquisition remains on track under the agreed terms. GSK said it still has separate patent cases against Pfizer and BioNTech in the U.S. and Europe, which are unaffected by this settlement. Related articles GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic USPS blocks major vape distributor over unregulated product shipments - Reuters Exclusive: Opendoor CEO Wheeler breaks silence, EMJ's Eric Jackson calls for more Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Patient's heartbreaking final words before death
"I want to go home." These were the last words spoken to a father by a young woman who died within hours of complications arising from elective weight loss surgery. Brooke Tiddy was admitted to St George Private Hospital in Sydney on September 19, 2018 for bariatric surgery recommended by her doctor, who assessed her as "super super obese". But her hopes for a new lease on life were dashed when the 32-year-old died two days later. An inquest into her death seeks to assess the effectiveness of the hospital's processes and prevent similar deaths. On Monday, her parents and two sisters remembered the mental health support worker as "an energetic and enthusiastic soul who would do anything for anyone". Ms Tiddy had been "deeply motivated to improve her health" and was "nervous but excited" when she embarked on the journey "she would never have a chance to complete". Her family said the passionate baker's life was cut tragically short by a failure to investigate her underlying health issues before her surgery. "This oversight cost Brooke her life and shattered her family's and friends' trust in the health system," they said in a statement. "We hope (this inquest) will lead to measures that ensure such preventable tragedies never happen again". The inquest was told Ms Tiddy lived with an "extremely rare" condition known as sponastrime dysplasia, which affects the muscles and skeletal system. Her surgeon Dr Vytauras Kuzinkovas said he hadn't previously heard of the condition and didn't do any research about it until after Ms Tiddy's death. One of the associated features is a narrowing of the airways which was ultimately found to be Ms Tiddy's cause of death, the inquest was told. An autopsy found her airways had severely narrowed to the approximate diameter of a drinking straw, which almost certainly occurred before the surgery. Dr Kuzinkovas said Ms Tiddy downplayed her asthma and depression and didn't reveal she had croup or narrow airways during an initial consultation. An in-depth assessment of her medical history would have likely revealed such risk factors, he said, but he hadn't thought it was needed at the time. With the benefit of hindsight, Dr Kuzinkovas accepted Ms Tiddy was a high-risk patient whom he would have referred to specialists before surgery. Intensive care unit staff looking after Ms Tiddy were not informed about her sponastrime dysplasia and its significance, the inquest was told. If he had been aware of the link between her condition and narrowed airways, ICU doctor Michael O'Leary said he would have called in a specialist. "This has been the worst experience I've had in my career. I felt very alone that night," he said. "The only thing looking back on it I would do differently would be to get someone else to give me a hand." Dr O'Leary said he wasn't sure whether a pre-operative assessment would have prevented MsTiddy's death because what they really needed was to access her full medical history. "In a sense we were set up to fail in this case because there was all of this information that was kept from us," he said. The inquest continues on Tuesday.
Medscape
an hour ago
- Medscape
Canadians Launch Country's First Black Medical Journal
The launch of Canada's first Black medical journal has been welcomed by the Black community as a major step towards promoting diversity in healthcare research. The Nigerian Canadian Medical Journal was launched on August 2 in Edmonton by the Canadian Association of Nigerian Physicians and Dentists (CANPAD). Hadal El-Hadi, MD 'This new journal can make a significant difference in addressing the health and social issues faced by Black Canadians,' Hadal El-Hadi, MD, founder of Black Physicians of Canada, told Medscape Medical News. 'By providing a dedicated platform for research, scholarship, and dialogue, it can elevate the voices of Black scholars and practitioners.' El-Hadi, who is not involved in the journal, added that it could further play a role in highlighting critical health disparities, promoting culturally relevant research, fostering interdisciplinary collaborations, and serving as a resource to guide the development of effective interventions and strategies that are tailored to the unique needs of Black communities. Journal to Fill Minority Gaps in Research The journal's editor-in-chief, Moses Ademola, MD, explained to Medscape Medical News that the aim was to create a peer-reviewed, open-access publication that provides fresh insights and a new global perspective that appeals to readers within and beyond the Nigerian community. 'We know from working around different teams that a diverse team improves outcomes for our patients, who, increasingly, are coming to us in diverse forms,' said Ademola, who is an emergency physician at Sturgeon Community Hospital, St. Albert, Alberta, and Royal Alexandra Hospital in Edmonton. 'The CANPAD journal was formed to enrich medical discourse, offer mentorship, and foster collaborative research. While the journal is published by a Black committee, it's aimed at a broad global audience. It's our hope and prayer that it will reflect the multicultural and inclusive values of Canada. We'll follow the science and go where we feel we can make a difference. We want to be a platform for voices that would otherwise be missed,' Ademola explained. Black Canadians Face Health Inequities A Government of Canada public health agency study published in 2020 reported that racism has been increasingly recognized as an important driver of inequitable health outcomes for visible minority Canadians. 'The healthcare challenges faced by Black Canadians are distinct due to historical factors, including the legacy of colonialism and systemic racism, which create unique barriers to care,' said El-Hadi. 'Black patients can experience discrimination within healthcare settings, leading to mistrust and inadequate treatment. Additionally, cultural differences in health perceptions and the stress from ongoing racism contribute to disparities in health outcomes,' she said. Lack of inclusion and diversity continues to be a source of concern for the Black community and public health organizations. 'Research gaps and health inequalities exist, and some of these are not modifiable,' explained Ademola. 'The Irish population tends to have cystic fibrosis. Blacks have a disproportionately high incidence of sickle cell disease. And Ashkenazi Jews are enriched for carriers of a fatal form of Tay-Sachs disease.' If clinicians aren't equipped to manage them well, the outcomes tend to be poorer, he said. El-Hadi said there is a need for focused research on chronic diseases within Black communities, particularly concerning the impact of racism and stress. Historically, the Black population in Canada and globally has been underrepresented in clinical research in terms of participation in clinical trials, as researchers, and in access to funding. Health studies often lack sufficient representation of Black Canadians, limiting understanding of their specific health needs. Cultural differences in health behaviors are also often overlooked, skewing data applicability. 'The medical community will have to work harder to ensure we don't end up with an unintended racial bias. The government must be intentional in ensuring that equity gaps are bridged. Scholars and scientists everywhere have to be aware of this blind spot. We need to work together so that health outcomes in all our population are similar,' said Ademola. Canada's Social Sciences and Humanities Research Council developed a work plan in 2020 to address anti-Black racism in research, leading to the establishment of an external advisory committee of Black researchers. The council says it aims to ensure that Black researchers have fair access to research support and is working with stakeholders to advance their equitable participation in the research ecosystem. Ademola and El-Hadi reported having no relevant financial relationships.
